Dr. Avisit Patil Breast cancer It is the second most common cancer in India (next) Cervical cancer).In India, breast cancer accounts for 22.2 percent of all...
The software being tested is from Vara, a German-based and research-led startup. The company’s AI is already in use in more than a quarter of German...
New treatments such as ado-trastuzumab emtansine (Kadcyla), fam-trastuzumab deruxtecan-nxki (Enhertu), and CDK4 / 6 inhibitors revolutionize treatment across breast cancer subtypes, according to Gregory Vidal, MD,...
According to the doctor who treated her, a woman from India has shown no evidence of breast cancer after clinical trials in a British hospital. A...
largely 34,000 Black women in the United States are diagnosed with breast cancer each year. Breast cancer is more likely to be metastatic (spreading to other...
“Convincing” data support the use of trastuzumab deluxtecan in patients with HER2-low metastatic breast cancer and sacituzumab gobitecan in patients with triple-negative breast cancer or hormone...
Recent Comments